EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Limonoid 7-Deacetoxy-7-oxogedunin (CG-1) Attenuates RANKL-Induced Osteoclastogenesis via Inhibiting PI3K/Akt-NFATc1 Axis

Atsushi Koike, Ko Fujimori iD

Cells · 07.05.2026 · 15 (10) · 854

DOI: 10.3390/cells15100854 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 07.05.2026. Verfasst von Atsushi Koike und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathobiochemistry, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki 569-1094, Osaka, Japan. Hauptthemen laut MEDLINE: RANK Ligand, NFATC Transcription Factors, Limonins, Proto-Oncogene Proteins c-akt. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Excessive bone resorption by osteoclasts causes pathological bone loss in diseases such as osteoporosis. 7-Deacetoxy-7-oxogedunin (CG-1), a limonoid isolated from Carapa guianensis (Meliaceae), exhibits various biological activities. Here, we examined the anti-osteoclastogenic effect of CG-1 and its underlying mechanism in receptor activator of NF-κB ligand (RANKL)-induced osteoclast differentiation of RAW264.7 cells. CG-1 inhibited the formation of tartrate-resistant acid phosphatase-positive multinucleated cells and decreased the expression of osteoclastogenesis-related genes. When CG-1 was added to the culture during the first 3 days of the 5-day-osteoclastogenesis period, the expression levels of the osteoclastogenesis-related genes (Nfatc1, Acp5, Src, Ctsk, and Mmp9) were decreased, as was observed when CG-1 was added continuously for 5 days. Furthermore, CG-1 lowered RANKL-induced Akt phosphorylation, which is similar to the results seen with the PI3K inhibitor, LY294002. Moreover, CG-1 and LY294002 suppressed the RANKL-induced expression of NFATc1, the master transcription factor for regulating terminal differentiation into osteoclasts. These results suggest that CG-1 attenuated RANKL-induced osteoclastogenesis by inhibiting the PI3K/Akt-NFATc1 axis during the early stage of osteoclast differentiation. Thus, CG-1 has the potential to suppress osteoclast-mediated bone resorption.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RANK LigandNFATC Transcription FactorsLimoninsProto-Oncogene Proteins c-aktOsteoclastsPhosphatidylinositol 3-KinasesOsteogenesisAnimalsMiceRAW 264.7 CellsCell DifferentiationSignal TransductionBone Resorption

Stichwörter der Autor:innen

7-deacetoxy-7-oxogedunin (CG-1)AktNFATc1RANKLlimonoidosteoclastogenesis

Substanzen

RANK LigandNFATC Transcription FactorsLimoninsProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesNfatc1 protein, mouse

Autor:innen und Institutionen

  • Department of Pathobiochemistry, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki 569-1094, Osaka, Japan.

ORCID-Profile: Ko Fujimori

Zitieren

APA

Koike, A., & Fujimori, K. (2026). Limonoid 7-Deacetoxy-7-oxogedunin (CG-1) Attenuates RANKL-Induced Osteoclastogenesis via Inhibiting PI3K/Akt-NFATc1 Axis. Cells, 15(10), 854. https://doi.org/10.3390/cells15100854

Vancouver

Koike A, Fujimori K. Limonoid 7-Deacetoxy-7-oxogedunin (CG-1) Attenuates RANKL-Induced Osteoclastogenesis via Inhibiting PI3K/Akt-NFATc1 Axis. Cells. 2026;15(10):854. doi:10.3390/cells15100854

BibTeX
@article{Koike2026,
  author = {Koike, Atsushi and Fujimori, Ko},
  title = {Limonoid 7-Deacetoxy-7-oxogedunin (CG-1) Attenuates RANKL-Induced Osteoclastogenesis via Inhibiting PI3K/Akt-NFATc1 Axis},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {10},
  pages = {854},
  doi = {10.3390/cells15100854}
}
Kostenlos starten →